Literature DB >> 32397931

Influence of Preexisting Cognitive Impairment on Clinical Severity of Ischemic Stroke: The Dijon Stroke Registry.

Yannick Béjot1, Gauthier Duloquin1, Valentin Crespy1, Jérôme Durier1, Lucie Garnier1, Mathilde Graber1, Maurice Giroud1.   

Abstract

Background and Purpose- The ongoing ageing population is associated with an increasing number of patients with stroke who have preexisting cognitive impairment. This study aimed to evaluate clinical severity in patients with ischemic stroke according to prestroke cognitive status. Methods- Patients with ischemic stroke were prospectively identified among residents of Dijon, France using a population-based registry (2013-2017). Prestroke cognitive status (no impairment, mild cognitive impairment [MCI], or dementia) was recorded, and severity at stroke onset was measured using the National Institutes of Health Stroke Scale (NIHSS) score. Association between prestroke cognitive status and severity was evaluated using ordinal regression analysis models in which the NIHSS score was considered as a categorical variable. Results- Among the 1048 patients (mean age, 76.3±15.2 years; 54.0% women), a greater severity was observed in those with MCI (n=132; median NIHSS: 6; interquartile range, 2-15), and those with dementia (n=164; median NIHSS: 7; interquartile range, 3-16), than in patients without cognitive impairment (n=752; median NIHSS: 3; interquartile range, 1-9). MCI (odds ratio [OR], 1.70 [95% CI, 1.21-2.38]; P=0.002) and dementia (OR, 2.24 [95% CI, 1.65-3.04]; P<0.001) were both associated with a greater severity at onset. The association was still observed after adjustment for clinical variables and proximal arterial occlusion (OR, 1.52 [95% CI, 1.02-2.28]; P=0.04 for MCI; OR, 2.16 [95% CI, 1.45-3.22]; P<0.001 dementia). Further adjustment for prestroke handicap slightly reduced the magnitude of the association (OR, 1.49 [95% CI, 0.98-2.25]; P=0.06 for MCI, and OR, 1.98 [95% CI, 1.26-3.12]; P=0.02 for dementia). The greater severity in patients with prestroke cognitive impairment was not specifically driven by a more severe impairment of either motor or language function. Conclusions- Patients with preexisting cognitive impairment suffered more severe ischemic stroke. This result could reflect a lower brain tolerance of acute ischemia. Further studies are needed to explore the underlying mechanisms that could be targeted from therapeutic perspectives focusing on neuroprotection.

Entities:  

Keywords:  dementia; epidemiology; odds ratio; prognosis; registries; stroke

Year:  2020        PMID: 32397931     DOI: 10.1161/STROKEAHA.119.028845

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan.

Authors:  Kazuo Washida; Erika Kitajima; Tomotaka Tanaka; Shuhei Ikeda; Tetsuya Chiba; Kotaro Noda; Takeshi Yoshimoto; Kazuki Fukuma; Satoshi Saito; Masafumi Ihara
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 2.  Potential nanotherapeutic strategies for perioperative stroke.

Authors:  Jingyi An; Ling Zhao; Ranran Duan; Ke Sun; Wenxin Lu; Jiali Yang; Yan Liang; Junjie Liu; Zhenzhong Zhang; Li Li; Jinjin Shi
Journal:  CNS Neurosci Ther       Date:  2022-03-04       Impact factor: 5.243

3.  Factors Influencing Post-Stroke Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.

Authors:  Zhao-Yin Ma; Yong-Ya Wu; Hong-Yin-Long Cui; Guang-Yan Yao; Hong Bian
Journal:  Clin Interv Aging       Date:  2022-04-29       Impact factor: 3.829

4.  Predictive value of serum adiponectin and hemoglobin levels for vascular cognitive impairment in ischemic stroke patients.

Authors:  Zhouling Li; Manlian Zhu; Cheng Meng; Hai Lin; Lifen Huang
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

5.  Pre-stroke cognitive impairment is associated with vascular imaging pathology: a prospective observational study.

Authors:  Till Schellhorn; Manuela Zucknick; Torunn Askim; Ragnhild Munthe-Kaas; Hege Ihle-Hansen; Yngve M Seljeseth; Anne-Brita Knapskog; Halvor Næss; Hanne Ellekjær; Pernille Thingstad; Torgeir Bruun Wyller; Ingvild Saltvedt; Mona K Beyer
Journal:  BMC Geriatr       Date:  2021-06-14       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.